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fludrocortisone, which was stopped before or during their 
sessions. Heart rate variability in the time domain (standard 
deviation of the beat-to-beat interval) increased post-HIR-
REM (mean increase 51 %, range 10–143, p = 0.03), as 
did baroreflex sensitivity (mean increase in high-frequency 
alpha 65 %, range −6 to 180, p = 0.05). Baseline tempo-
ral electrical asymmetry negatively correlated with change 
in asymmetry from assessment to the final HIRREM ses-
sion (p = 0.01). Summed high-frequency amplitudes at 
left and right temporal lobes decreased a median of 3.8 μV 
(p = 0.02). There was a trend for improvements in self-
reported symptoms related to the autonomic nervous sys-
tem. Use of HIRREM was associated with reduced sympa-
thetic bias in autonomic cardiovascular regulation, greater 
symmetry and reduced amplitudes in temporal lobe high-
frequency electrical activity, and a trend for reduced auto-
nomic symptoms. Data suggest the potential for allostatic 
neurotechnology to facilitate increased flexibility in auto-
nomic cardiovascular regulation, possibly through more 
balanced activity at regions of the neocortex responsible for 
autonomic management.
Clinical trial registry “Tilt Table with Suspected postural 
orthostatic tachycardia syndrome (POTS) Subjects,” Proto-
col Record: WFUBAHA01.
Keywords POTS · Autonomic dysregulation · Nausea · 
Allostasis · Neurotechnology · Hemispheric asymmetry
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Abstract Autonomic dysregulation and heterogeneous 
symptoms characterize postural orthostatic tachycardia 
syndrome (POTS). This study evaluated the effect of high-
resolution, relational, resonance-based, electroencephalic 
mirroring (HIRREM®), a noninvasive, allostatic neurotech-
nology for relaxation and auto-calibration of neural oscilla-
tions, on heart rate variability, brain asymmetry, and auto-
nomic symptoms, in adolescents with POTS. Seven subjects 
with POTS (three males, ages 15–18) underwent a median 
of 14 (10–16) HIRREM sessions over 13 (8–17) days. 
Autonomic function was assessed from 10-min continu-
ous heart rate and blood pressure recordings, pre- and post-
HIRREM. One-minute epochs of temporal high-frequency 
(23–36 Hz) brain electrical activity data (T3 and T4, eyes 
closed) were analyzed from baseline HIRREM assessment 
and subsequent sessions. Subjects rated autonomic symp-
toms before and after HIRREM. Four of seven were on 
Data from this study were presented in poster form at the annual 
meeting of the American Autonomic Society, Kohala Coast, 
Hawaii, October 23–26, 2013.
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Hz  Hertz
HIRREM  High-resolution, relational, resonance-based, 
electroencephalic mirroring
LF  Low frequency
µV  Microvolts
HUT  Head upright tilt test
POTS  Postural orthostatic tachycardia syndrome
SD  Standard deviation
SDNN  Standard deviation of the normal-to-normal 
interval
Introduction
The pervasive role of the autonomic nervous system for 
regulating functionality across organ systems and behaviors 
is often underappreciated in both adult and pediatric medi-
cine (Rees 2014). For example, unexplained gastrointesti-
nal symptoms are common in children (Hyams et al. 1996), 
and autonomic testing for children with functional abdomi-
nal pain can reveal differences in pathophysiology that 
may be indicative of an underlying dysautonomia (Safder 
et al. 2009). One such dysautonomia is postural orthos-
tatic tachycardia syndrome, or POTS, defined as excessive 
increase in heart rate (HR) upon upright posture (Freeman 
et al. 2011; Ojha et al. 2011). POTS may present with het-
erogeneous symptoms including palpitations, shortness of 
breath, sleep disturbance, fatigue, nausea, abdominal pain, 
headache, lightheadedness, or syncope. Treatment may 
include agents intended to remediate dysregulation across 
cardiovascular, gastrointestinal, and neuropsychiatric sys-
tems, including mineralocorticoids or saline for volume 
expansion, beta-blockers and other autonomic medications, 
and others (Raj et al. 2005; Garland et al. 2007). Yet the 
genesis of POTS symptomatology is likely multifactorial 
involving numerous descending structures of the central 
autonomic network including the brainstem, amygdala, 
insula, anterior cingulate cortex, hypothalamus, periaque-
ductal gray, and others, and there is an important role for 
behavioral or other interventions that can impact this net-
work systematically on a top-down basis (Benarroch 2012).
Studies have shown that at the level of the cerebral hemi-
spheres, regulation of the autonomic nervous system (ANS) 
is lateralized, with the right and left sides being associ-
ated with sympathetic and parasympathetic management, 
respectively (Zamrini et al. 1990; Oppenheimer et al. 1992; 
Yoon et al. 1997; Hilz et al. 2001; Lee et al. 2014). Fur-
thermore, there is evidence that it may be possible to detect 
asymmetrical contributions of the cerebral hemispheres 
to management of the autonomic nervous system through 
the use of noninvasive scalp recordings. Changes in corti-
cal potential measured from the left temporal scalp have 
been shown to correlate with measures of cardiac function 
(Gray et al. 2007), and rightward dominance in temporal 
high-frequency brain electrical asymmetry calculated from 
scalp measures has been shown to correspond to higher rest-
ing heart rate and lower baroreflex sensitivity in a hetero-
geneous population (Tegeler et al. 2015b). Neurotechnology 
interventions have been shown to have a role for modulat-
ing autonomic activity through engagement with patterns of 
lateralized activity in cortical regions associated with ANS 
management. Transcranial direct current stimulation at the 
left temporal lobe, for example, is an “open-loop” approach 
(one that provides stimulus without recording brain activ-
ity) that has been applied at the left temporal region in order 
to augment parasympathetic functioning and potentially 
enhance performance in cyclists (Okano et al. 2015).
The potential contribution of hemispheric lateralization 
patterns to autonomic dysregulation in POTS has not previ-
ously been explored. High-resolution, relational, resonance-
based, electroencephalic mirroring (HIRREM®) is a novel, 
noninvasive closed-loop neurotechnology designed to facili-
tate relaxation and auto-calibration of neural oscillations. 
HIRREM monitors brain electrical activity at high spectral 
resolutions using two-channel recordings (Gerdes et al. 
2013). It applies software algorithms to generate unique 
and changing patterns of acoustic stimulation (tones of vari-
able pitch and timing) that are based on real-time changes 
in dominant frequencies of brain electrical activity. In a ran-
domized, controlled pilot trial for individuals with insom-
nia, use of HIRREM was associated with improved sleep 
and reduced depressive symptoms (Tegeler et al. 2012), 
and in an open-label study of patients with heterogeneous 
symptoms, use of HIRREM was associated with reduction 
in temporal lobe high-frequency electrical asymmetry and 
increased heart rate variability (Tegeler et al. 2013).
Presently, we report on the use of HIRREM in a series 
of adolescents with nausea and orthostatic symptoms who 
were diagnosed with POTS by an abnormal head upright 
tilt (HUT) test. Specifically, we examined pre- to post-
HIRREM change in outcome measures of autonomic car-
diovascular regulation including: heart rate variability as 
measured by standard deviation of the beat-to-beat interval 
(SDNN), baroreflex sensitivity (BRS), asymmetry in tem-
poral lobe high-frequency (23–36 Hz) electrical activity, 
the sum of right and left temporal high-frequency electrical 
amplitudes, and autonomic symptom scores.
Methods
Subject recruitment and selection
Subjects for this study were recruited from the pediat-
ric gastroenterology clinic of Wake Forest Baptist Medi-
cal Center, in whom evaluation of chronic unexplained 
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nausea and orthostatic symptoms (dizziness, flushing, 
tachycardia, shortness of breath with standing) revealed 
an abnormal cardiovascular response to HUT. We spe-
cifically included only subjects meeting criteria for POTS 
(Fortunato et al. 2011). A convenience sample of seven 
of these patients (three male, ages 15–18, one Asian, one 
African-American) was invited to enroll in an ongoing 
open-label, single-site, IRB-approved, feasibility study of 
HIRREM for individuals with diverse psychophysiological 
conditions, conducted by the Department of Neurology. 
Informed consent was obtained from all individual partici-
pants (18 years of age or greater) included in the study. For 
those subjects less than 18 years of age, a study consent 
was obtained from the patient’s parent or legal guardian, 
as well as a separate assent from the patient. Four of the 
seven subjects were taking fludrocortisone prior to enroll-
ment, which was discontinued before or during HIRREM 
in all four.
Head upright tilt (HUT) table test
The tilt table evaluation was done using standard methods, 
previously reported (Fortunato et al. 2011). After 15-min 
supine, there was an immediate upright tilt from 0° to 70°. 
The table remained at 70° for 45 min, before being returned 
to supine for another 15 min. Pulse oximetry and HR were 
monitored continuously, with blood pressure (BP) mon-
itored every 2 min. POTS was defined as either a HR of 
greater than 120 beats per minute (bpm) or an increase of 
40 bpm from baseline in the first 10 min of tilt, sustained 
for 2 min or more in the absence of hypotension (i.e., 
reduction in systolic blood pressure greater than 20 mmHg; 
Low et al. 2009). All participants included in this study met 
HUT criteria for POTS.
Assessment of autonomic cardiovascular regulation
After meeting the eligibility criteria discussed above, each 
participant completed a pre-HIRREM visit for enrollment 
and data collection. Continuous BP and HR were acquired 
from noninvasive finger arterial pressure measurements and 
electrocardiogram for a minimum of 10 min with subjects 
lying down quietly, supine. Recordings were obtained at 
the baseline HIRREM enrollment visit, and a median of 
8 days (range 0–32) after completion of the last HIRREM 
session. Systolic BP and beat-to-beat, RR intervals (RRI) 
files generated via the data acquisition system (BIOPAC 
acquisition system and Acknowledge 4.2 software, Santa 
Barbara, CA) at 1000 Hz were analyzed using Nevrokard 
BRS software (Nevrokard BRS, Medistar, Ljubljana, Slo-
venia), and analysis was conducted on the first complete 
5-min epoch that was considered to be acceptable for 
analysis. For calculation of SDNN, the R–R intervals were 
visually inspected, and the data considered as artifact were 
manually removed. Spectral power was calculated with fast 
Fourier transform (FFT) with high-frequency (HF) power 
band set as (0.15–0.40 Hz) and low-frequency (LF) power 
band (0.04–0.15 Hz) on segment length 128 points, 50 % 
overlap. Recording periods of 256 s were analyzed, each 
yielding 512 data points after re-sampling at the 2-Hz fre-
quency with the application of Hanning window. Spectral 
measures of BRS including low-frequency (LF) and high-
frequency (HF) alpha indices were also calculated (Parati 
et al. 1995; Maestri et al. 2005).
Self‑reported nausea, dizziness, and autonomic 
symptoms
Subjects completed a Nausea/Dizziness Questionnaire 
which included 14 items related to nausea, dizziness, and 
autonomic regulation, rated on a Likert scale from 0 (none) 
to 4 (severe) for each item. Questionnaires were completed 
1–2 weeks before HUT test and at the same visit as the 
post-HIRREM blood pressure recording.
HIRREM process
Procedures for the provision of HIRREM have been dis-
cussed in detail previously (Gerdes et al. 2013). Prior to 
starting the HIRREM sessions, each participant had a 
baseline assessment to evaluate brain electrical frequen-
cies and amplitudes. The HIRREM assessment (approxi-
mately 45 min) consisted of two-channel recordings of 
brain electrical activity from at least six paired locations 
on the scalp (F3/F4, C3/C4, T3/T4, P3/P4, FZ/OZ, and 
O1/O2) with HIRREM equipment (Brain State Technolo-
gies, Scottsdale, Arizona) that samples at 256 Hz, using 
a 16-bit A/D convertor with notch filter for rejection of 
signal >50 dB at 50 or 60 Hz, with signal processing per-
formed on a 64-bit computer processor. Recordings were 
conducted at each location with eyes closed (1 min), eyes 
partially open to permit transition in arousal state (1 min), 
and eyes open (1 min while performing a mental task, e.g., 
recalling numbers and reading a passage). Data collected 
were subject to analysis in HIRREM software to permit 
visual and quantitative assessment of the relative symmetry 
between homologous brain regions, as well as the propor-
tionation or distribution of amplitudes across different fre-
quency bands at each location. Assessment data were then 
used to choose protocols for the initial HIRREM session. A 
typical HIRREM session (approximately 90 min) consisted 
of four to ten HIRREM protocols (6–30 min each), some 
done with eyes closed and some with eyes open, with the 
participant being asked to relax while sitting or reclining 
comfortably in a chair. Most protocols consisted of record-
ing brain electrical activity through two channels, using 
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sensors placed at homologous regions of the hemispheres, 
and analyzing rhythms using software designs that include 
proprietary mathematical algorithms, with occasional pro-
tocols entailing recording at a single cortical region with 
one channel (Gerdes et al. 2013). Software designs mir-
ror cortical activity in specific frequency ranges, to sup-
port de-establishment of relatively invariant and potentially 
maladaptive activity patterns. Algorithms selected specific 
ranges of the brain electrical frequency spectrum, identi-
fied dominant frequencies in a middle range, and translated 
those frequencies to acoustic stimulation (auditory tones of 
variable pitch and timing) that was presented to participants 
through standard earphones (Creative EP-630 or Sony Ste-
reo Headphones MDR-EX58V) with a delay of 8 ms at the 
lower limits. Volume (decibels) of acoustic stimulation was 
adjusted by each participant in accordance with their pref-
erence. Specific protocols for successive HIRREM sessions 
were chosen based on brain electrical data from the pre-
ceding session, which for purposes of technologist review 
was aggregated in broadband frequency bins (<1.0 Hz; 
1.0–3.0 Hz; 3.0–5.5 Hz; 7.5–10.0 Hz; 10.0–12.0 Hz; 12.0–
15.0 Hz; 15.0–23.0 Hz; 23.0–36.0 Hz; 36.0–48.0 Hz). Spe-
cial attention was given to activity set points suggestive of 
dominant hemispheric asymmetries or proportionations 
of energy across the frequency spectrum considered to be 
potentially suboptimal (Gerdes et al. 2013). Participants 
generally completed two HIRREM sessions in a half day, 
separated by a 20- to 30-min break, and they received a 
median of 14 (10–16) sessions over 13 (8–17) days.
Brain electrical activity changes
Temporal high-frequency (23–36 Hz) electrical asymmetry 
scores were calculated using 1-min epochs from the base-
line assessment (T3/T4, eyes closed), and data from the 
penultimate minute of the penultimate HIRREM exercise at 
temporal locations (T3/T4, eyes closed), using the formula 
natural log (T4/T3) so that positive values indicate right-
ward dominance. The same data were also used to calculate 
values for the sum of temporal lobe high-frequency ampli-
tudes (microvolts, µV) to explore for change in temporal 
lobe cortical arousal.
Statistical analysis
Data are presented as mean percentage changes for auto-
nomic cardiovascular regulation measures, mean values 
for symptom scores by individual item and the sum of 
all items, and median values for brain electrical activity. 
Changes in autonomic cardiovascular regulation measures, 
symptom scores, and sum of temporal lobe high-frequency 
amplitudes were evaluated using paired t tests. A correction 
strategy (e.g., Bonferroni) was not planned for the multiple 
comparisons entailed in analysis of the autonomic meas-
ures and symptom scores, because of likely correlation 
between the various measures and the exploratory nature 
of the study. Spearman’s correlation coefficient was used 
to estimate the correlation between baseline temporal lobe 
high-frequency electrical asymmetry and the change in 
asymmetry as measured at the final HIRREM session.
Results
Changes in autonomic cardiovascular regulation 
and self‑reported symptoms
Table 1 shows changes in measures of autonomic car-
diovascular regulation after subjects completed their HIR-
REM sessions. Data for SDNN, LF, and HF were not 
included for one subject who had frequent cardiac irregu-
larities on the baseline assessment. Mean scores for each 
question of the Nausea/Dizziness Questionnaire, before 
and after HIRREM, are shown in Table 2. All subjects 
Table 1  Changes in measures of autonomic cardiovascular regulation, from baseline to after completion of HIRREM sessions
Median value at baseline 
(range)
Median value after HIRREM 
(range)
Mean percentage change (range) p value
LF alpha (ms/mmHg) 20 (12–43) 29.3 (13–34) +28 (−27 to 127) >0.2
HF alpha (ms/mmHg) 20.5 (12–53) 35.3 (17–77) +65 (−6 to 180) 0.04
BRS sequence up (ms/mmHg) 16.6 (12–49) 25 (14–56) +33 (−18 to 134) 0.18
BRS sequence down (ms/mmHg) 26.8 (12–40) 24.6 (12–63) +54 (−63 to 260) >0.2
BRS sequence all (ms/mmHg) 19 (12–47) 24.9 (15–61) +37 (−40 to 177) >0.2
SDNN (ms) 39 (35–92) 71 (44–120) +51 (10 to 143) 0.03
LF (ms2) 854 (278–4552) 1167 (587–2326) +43 (−73 to 167) >0.2
HF (ms2) 917 (235–5204) 1605 (273–4769) +107 (−32 to 372) >0.2
MAP (mmHg) 79 (71–100) 79 (71–87) −4 (−22 to 15) >0.2
HR (beat/min) 65 (53–87) 73 (60–90) +7 (−6 to 33) >0.2
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whose fludrocortisone had been discontinued were able to 
remain off it following HIRREM. No adverse events were 
reported, and there were no dropouts.
Changes in temporal lobe high‑frequency electrical 
activity
Figure 1a, b shows spectrographs of brain electrical activ-
ity that typify shifts seen in temporal lobe brain electrical 
asymmetry in the high frequency range (and other ranges) 
over the course of HIRREM in one of the participants, a 
15-year-old female. Relatively high amplitudes are seen 
especially in the high frequency ranges for both the left 
and right temporal lobes during the baseline assessment 
(a), and more so for the right. By the penultimate session 
(b), amplitudes are lower, and the two sides are relatively 
symmetrical. There was a negative correlation (Fig. 2)
between baseline asymmetry score and the change in 
asymmetry score, calculated as final session asymmetry 
less baseline asymmetry (ρ = −0.89, p = 0.01). A statisti-
cally significant reduction was observed in the sum of the 
temporal high-frequency amplitudes (T3 plus T4) from 
baseline to the final session (median change = −3.8 µV, 
range = −17.8 to −0.7 µV, p = 0.02).
Discussion
In this pilot study of adolescents with chronic nausea and 
POTS confirmed by abnormal HUT test, the use of HIR-
REM was associated with the increase in heart rate variabil-
ity in the time domain (SDNN) and BRS in the frequency 
domain (HF alpha). Exploratory analyses of left and right 
temporal lobe electrical activity patterns showed reduc-
tions in both asymmetry and summed amplitudes in a high 
frequency (23–36 Hz) range. There were trends for reduc-
tions in self-reported nausea, dizziness, and autonomic 
symptoms, and those who were previously using fludrocor-
tisone (four subjects) were able to discontinue that medica-
tion. The intervention was well tolerated, no adverse events 
occurred, and there were no dropouts.
Heart rate variability biofeedback may support symptom 
reduction and improved autonomic regulation in children 
with functional abdominal pain (Sowder et al. 2010), and 
therapeutic peripheral sensory stimulation (e.g., acupunc-
ture) is reported to elicit reductions in abdominal symp-
toms, alterations in gastric slow waves, and increased heart 
rate variability (Liu et al. 2012; Witt et al. 2012; Zhang 
et al. 2015). The present report is consistent with these 
studies, and to our knowledge, it is the first to show that 
use of a nonpharmacological intervention is associated with 
increased heart rate variability and BRS, measures that are 
indicative of relative parasympathetic activation, in patients 
with POTS. Given that POTS is characterized by sympa-
thetic bias (Shaltout et al. 2014) and that higher SDNN and 
HF alpha are indicative of relative parasympathetic activa-
tion, we infer that use of HIRREM in these participants 
facilitated more optimal autonomic functionality. Though 
all these approaches involve some degree of neocorti-
cal engagement, theoretically there may be advantages to 
interventions that can support the brain itself to optimize 
its activity, if it is possible to leverage its orchestrative role 
as the organ of central command, and in consideration of 
multiplier effects that can be realized through influence at 
higher levels of a system’s regulation.
The subjects’ changes in brain electrical activity patterns 
were consistent with previously reported observations of 
trends toward reduction in temporal high-frequency asym-
metry and amplitudes among individuals enrolled in clini-
cal trials of HIRREM for insomnia and menopausal hot 
flashes (Tegeler et al. 2012, 2015a; Gerdes et al. 2013). 
Increased high-frequency amplitudes have been implicated 
in hyperarousal associated with insomnia and menopausal 
hot flashes (Perlis et al. 2001; Campbell et al. 2011), and 
it would appear plausible that a decrease in temporal high-
frequency amplitudes could also be consequential for some 
symptomatology associated with POTS. Preliminarily, 
we interpret the changes in temporal lobe high-frequency 
asymmetry and amplitudes to be consistent with a model 
of technology-assisted brain self-optimization, wherein the 
brain is facilitated through HIRREM to update itself with 
respect to its neural oscillatory patterns at key regions of 
the cortex. Iterated self-updating may support the brain to 
make self-adjustments to activity patterns including mecha-
nisms for autonomic regulation.
Table 2  Scores for self-reported intensity of nausea, dizziness, and 
general autonomic symptoms, on 0–4 Likert scale, before and after 
using HIRREM
V1 mean (SD) V2 mean (SD) p value
Nausea 1.3 (0.8) 1.1 (0.9) >0.2
Vomiting 0.4 (0.5) 0.0 (0) 0.08
Dizziness/lightheadedness 2.4 (1.0) 1.7 (0.8) 0.008
Passing out (syncope) 0.3 (0.8) 0.3 (0.8) >0.2
Abdominal pain 1.6 (1.4) 1.4 (1.6) >0.2
Constipation 0.7 (1.1) 0.4 (1.1) 0.17
Poor appetite 1.6 (1.4) 1.3 (1.3) >0.2
Fatigue 2.6 (1.5) 1.7 (1.4) 0.08
Missing school 1.9 (1.3) 0.9 (1.2) 0.11
Feeling flushed, sweaty 1.4 (1.1) 0.7 (0.8) 0.14
Shortness of breath 1.3 (1.3) 1.0 (1.2) >0.2
Chest pain 0.7 (1.3) 0.3 (0.5) 0.20
Heart racing 1.6 (1.5) 0.6 (1.1) 0.16
Headaches 2.3 (1.5) 1.7 (1.1) >0.2
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The idea that “continual updating of knowledge [infor-
mation] stores” (Sterling 2014) could be a basis for prin-
cipled therapeutics is one of the tenets of the advanced 
model of physiological regulation known as allosta-
sis (Sterling 2004, 2012), or “stability through change.” 
It has been proposed that allostasis has the potential to 
replace the conventional model of homeostasis (“stability 
through constancy”) through its definition of health as a 
state of optimal predictive fluctuation and its recognition, 
consistent with evolutionary theory, that fitness for life 
requires flexible adaptability of an organism’s operational 
set points across various system functionalities. Under 
allostasis, the brain is understood to serve as the master 
organ of central command, allocating resources so as to 
optimize responsivity to complex environmental contexts.
When the brain perceives the environment in a way that 
drives it to alter various system set points (e.g., increased 
sympathetic arousal related to chronic psychosocial 
Fig. 1  a, b FFT spectral 
display of electroencephalic 
data with frequency (Hertz, Hz, 
central Y axis) plotted against 
transformed amplitude (micro-
volts, µV, X axis). These graphs 
from a study subject represent 
1 min of data from the T3/T4 
montage with eyes closed (EC) 
at the baseline assessment (a) 
and at the penultimate minute 
of the penultimate session 
(b). Columns to the left and 
right denote ten frequency 
bands of aggregated data (00: 
<1.0 Hz; 10: 1.0–3.0 Hz; 20: 
3.0–5.5 Hz; 30: 5.5–7.5 Hz; 40: 
7.5–10.0 Hz; 50: 10.0–12.0 Hz; 
60: 12.0–15.0 Hz; 70: 15.0–
23.0 Hz; 80: 23.0–36.0 Hz; 
and 90: 36.0–48.0 Hz) and 
numerical values for averages in 
those ranges. Amplitudes in the 
23–36 Hz range (dark purple 
color) are outlined by red boxes
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stressors), neuroplasticity presents the potential for these set 
points to become dominant, with implications for functional-
ity of any or all organ systems that are subject to neural regu-
lation. An allostatic view of health implies that disease states 
can be expressed that are not the consequence of any intrin-
sic malfunctioning in biochemical or physiological mecha-
nisms. Relatedly, in its recognition of the brain as the organ 
of central command, the allostasis concept may explain the 
comorbidity of psychological and somatic symptoms dem-
onstrated in POTS and other autonomic disorders (Benarroch 
2012; Tarbell et al. 2014). Furthermore, allostasis invokes the 
need for therapeutics that facilitate the brain’s natural learn-
ing capacities and dynamic responsivity to the full range of 
ambient signals, as opposed to the clamping of system set 
points toward standardized response levels (Sterling 2014).
The findings of the present study suggest that an allostatic 
neurotechnology—one that is brain-centric, change-oriented, 
and intended for purposes of self-optimization—merits fur-
ther investigation as a means to support improved autonomic 
regulation through endogenous brain processes. Though 
physical mechanisms through which HIRREM may facili-
tate auto-calibration of neural oscillations are unknown, it 
is our conjecture that every individual has unique templates 
for his or her own patterns of brain activity as measured in 
the frequency domain—no less than they have unique finger-
prints—and that any given individual oscillatory pattern is 
subject to disturbance for a myriad of reasons. On the basis of 
thermodynamic physical law whereby energy is neither cre-
ated nor destroyed, it is plausible that presentation of serial 
acoustic tones that are resonant with dominant and changing 
brain frequencies may create opportunities for accretion or 
dissipation of neural energy in directions that are aligned with 
recovery of an individual’s own unique oscillatory templates.
This study was exploratory, and our inferences regard-
ing the present findings are limited by the modest number 
of subjects. Because there was no active control group, we 
cannot rule out the possibility that some component of the 
results might be due to subjective expectation or “placebo 
responding.” We are not aware of data to suggest that sub-
jective expectation alone could produce changes in both 
heart rate variability and temporal lobe electrical activity, of 
the magnitude demonstrated. Recently, it has been reported, 
for example, that patients with POTS who received an oral 
placebo demonstrated no change in heart rate beyond that 
attributable to background cardiovascular variability (Nwa-
zue et al. 2014), though it is also important to consider that 
the HIRREM intervention entails greater subjective engage-
ment than ingestion of a substance. Future studies may be 
designed to incorporate control interventions that entail 
alternative allostatic strategies (behavioral interventions) to 
evaluate the relative effect size associated with HIRREM, 
and studies with larger sample sizes and longer follow-up 
may help ascertain whether baseline asymmetry contributes 
to clinical improvement, as well as the duration of measured 
benefits. Furthermore, the use of more detailed and validated 
symptom questionnaires to assess symptoms at baseline as 
well as longitudinally will be essential to more objectively 
define the impact of treatment strategies such as HIRREM.
In conclusion, the present study showed that in a case 
series of adolescents with POTS, use of a closed-loop acous-
tic stimulation intervention, HIRREM, was associated with 
improved autonomic regulation, reduction in temporal high-
frequency electrical asymmetry and amplitudes, and a trend 
toward reduction in autonomic symptomatology. The find-
ings suggest it may be possible to impact peripheral auto-
nomic physiology through noninvasive interaction with lat-
eralized activity patterns at the level of the cerebral cortex. 
Given the absence of evidence-based therapies for ortho-
static intolerance associated with nausea, and side effects 
typically associated with pharmacological strategies directed 
at the autonomic nervous system, further study of allostatic 
neurotechnology such as HIRREM appears warranted.
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